Real-world experience of arbidol for Omicron variant of SARS-CoV-2.

Jingya Zhao,Yong Li, Rong Chen,Yanping Xu,Qingyuan Yang, Haiqing Zhang,Zhengxin Yin, Weiting Gu,Jinsong Hu,Li Chen,Jian Li,Guang Ning,Qijian Cheng,Min Zhou,Jieming Qu

Journal of thoracic disease（2023）

引用 0|浏览14

暂无评分

摘要

As a whole, arbidol may represent an effective and safe treatment in asymptomatic-mild patients suffering from Omicron variant during the pandemic of coronavirus disease 2019 (COVID-19).

查看译文

关键词

Arbidol,Omicron,efficacy,safety,severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要